2015-2025 Global Opioid Induced Constipation (OIC) Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

2015-2025 Global Opioid Induced Constipation (OIC) Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid Induced Constipation (OIC) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid Induced Constipation (OIC) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid Induced Constipation (OIC) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid Induced Constipation (OIC) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Opioid Induced Constipation (OIC) Drugs Production Forecast
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Opioid Induced Constipation (OIC) Drugs Forecast by Type
Table Global Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Opioid Induced Constipation (OIC) Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Opioid Induced Constipation (OIC) Drugs Forecast by End-Use (2020E-2025F)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Opioid Induced Constipation (OIC) Drugs Forecast by Region (2020E-2025F)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Opioid Induced Constipation (OIC) Drugs Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Ironwood Pharmaceuticals Inc
9.1.1 Ironwood Pharmaceuticals Inc Profile
Table Ironwood Pharmaceuticals Inc Overview List
9.1.2 Ironwood Pharmaceuticals Inc Products & Services
9.1.3 Ironwood Pharmaceuticals Inc Company Dynamics & News
9.1.4 Ironwood Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Daiichi Sankyo Co Ltd
9.2.1 Daiichi Sankyo Co Ltd Profile
Table Daiichi Sankyo Co Ltd Overview List
9.2.2 Daiichi Sankyo Co Ltd Products & Services
9.2.3 Daiichi Sankyo Co Ltd Company Dynamics & News
9.2.4 Daiichi Sankyo Co Ltd Business Operation Conditions
Table Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Pfizer
9.3.1 Pfizer Profile
Table Pfizer Overview List
9.3.2 Pfizer Products & Services
9.3.3 Pfizer Company Dynamics & News
9.3.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Progenics Pharmaceuticals Inc
9.4.1 Progenics Pharmaceuticals Inc Profile
Table Progenics Pharmaceuticals Inc Overview List
9.4.2 Progenics Pharmaceuticals Inc Products & Services
9.4.3 Progenics Pharmaceuticals Inc Company Dynamics & News
9.4.4 Progenics Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Shionogi & Co., Ltd
9.5.1 Shionogi & Co., Ltd Profile
Table Shionogi & Co., Ltd Overview List
9.5.2 Shionogi & Co., Ltd Products & Services
9.5.3 Shionogi & Co., Ltd Company Dynamics & News
9.5.4 Shionogi & Co., Ltd Business Operation Conditions
Table Business Operation of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Allergan Plc
9.6.1 Allergan Plc Profile
Table Allergan Plc Overview List
9.6.2 Allergan Plc Products & Services
9.6.3 Allergan Plc Company Dynamics & News
9.6.4 Allergan Plc Business Operation Conditions
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Nektar Therapeutics
9.7.1 Nektar Therapeutics Profile
Table Nektar Therapeutics Overview List
9.7.2 Nektar Therapeutics Products & Services
9.7.3 Nektar Therapeutics Company Dynamics & News
9.7.4 Nektar Therapeutics Business Operation Conditions
Table Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Purdue Pharma
9.8.1 Purdue Pharma Profile
Table Purdue Pharma Overview List
9.8.2 Purdue Pharma Products & Services
9.8.3 Purdue Pharma Company Dynamics & News
9.8.4 Purdue Pharma Business Operation Conditions
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 S.L.A. Pharma AG
9.9.1 S.L.A. Pharma AG Profile
Table S.L.A. Pharma AG Overview List
9.9.2 S.L.A. Pharma AG Products & Services
9.9.3 S.L.A. Pharma AG Company Dynamics & News
9.9.4 S.L.A. Pharma AG Business Operation Conditions
Table Business Operation of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Mundipharma International Limited
9.10.1 Mundipharma International Limited Profile
Table Mundipharma International Limited Overview List
9.10.2 Mundipharma International Limited Products & Services
9.10.3 Mundipharma International Limited Company Dynamics & News
9.10.4 Mundipharma International Limited Business Operation Conditions
Table Business Operation of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Ono Pharmaceutical Co., Ltd
9.11.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
9.11.2 Ono Pharmaceutical Co., Ltd Products & Services
9.11.3 Ono Pharmaceutical Co., Ltd Company Dynamics & News
9.11.4 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Overview List
9.12.2 Takeda Pharmaceutical Company Limited Products & Services
9.12.3 Takeda Pharmaceutical Company Limited Company Dynamics & News
9.12.4 Takeda Pharmaceutical Company Limited Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
9.13 Theravance Biopharma Inc
9.13.1 Theravance Biopharma Inc Profile
Table Theravance Biopharma Inc Overview List
9.13.2 Theravance Biopharma Inc Products & Services
9.13.3 Theravance Biopharma Inc Company Dynamics & News
9.13.4 Theravance Biopharma Inc Business Operation Conditions
Table Business Operation of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Valeant Pharmaceuticals International
9.14.1 Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Overview List
9.14.2 Valeant Pharmaceuticals International Products & Services
9.14.3 Valeant Pharmaceuticals International Company Dynamics & News
9.14.4 Valeant Pharmaceuticals International Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Cost, Gross Margin)
9.15 Cosmo Pharmaceuticals SA
9.15.1 Cosmo Pharmaceuticals SA Profile
Table Cosmo Pharmaceuticals SA Overview List
9.15.2 Cosmo Pharmaceuticals SA Products & Services
9.15.3 Cosmo Pharmaceuticals SA Company Dynamics & News
9.15.4 Cosmo Pharmaceuticals SA Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals SA (Sales Revenue, Cost, Gross Margin)
9.16 Daewoong Pharmaceutical
9.16.1 Daewoong Pharmaceutical Profile
Table Daewoong Pharmaceutical Overview List
9.16.2 Daewoong Pharmaceutical Products & Services
9.16.3 Daewoong Pharmaceutical Company Dynamics & News
9.16.4 Daewoong Pharmaceutical Business Operation Conditions
Table Business Operation of Daewoong Pharmaceutical (Sales Revenue, Cost, Gross Margin)
9.17 C.B. Fleet Company
9.17.1 C.B. Fleet Company Profile
Table C.B. Fleet Company Overview List
9.17.2 C.B. Fleet Company Products & Services
9.17.3 C.B. Fleet Company Company Dynamics & News
9.17.4 C.B. Fleet Company Business Operation Conditions
Table Business Operation of C.B. Fleet Company (Sales Revenue, Cost, Gross Margin)
9.18 Sucampo Pharmaceuticals
9.18.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
9.18.2 Sucampo Pharmaceuticals Products & Services
9.18.3 Sucampo Pharmaceuticals Company Dynamics & News
9.18.4 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Opioid Induced Constipation (OIC) Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid Induced Constipation (OIC) Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio in 2020E
Figure America Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio in 2020E
Figure Asia Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio in 2020E
Figure Oceania Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio in 2020E
Figure Africa Opioid Induced Constipation (OIC) Drugs Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Opioid Induced Constipation (OIC) Drugs INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Opioid Induced Constipation (OIC) Drugs INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation (OIC) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation (OIC) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Ironwood Pharmaceuticals Inc Overview List
Table Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Overview List
Table Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Overview List
Table Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Overview List
Table Business Operation of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc Overview List
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics Overview List
Table Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Purdue Pharma Overview List
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Overview List
Table Business Operation of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma International Limited Overview List
Table Business Operation of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Overview List
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Overview List
Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
Table Theravance Biopharma Inc Overview List
Table Business Operation of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Overview List

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs